East Sussex Healthcare NHS Trust
Oncotype DX Breast Cancer Testing
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the lower-middle of the Health & Social Care band — a mid-scale opportunity. Based on 32,734 valued Health & Social Care tenders in our corpus.
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer.
It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial versus where endocrine therapy alone is sufficient.
Make the case to bid
Reveal who to approach at East Sussex Healthcare NHS Trust, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- be83749f-55db-4eb4-b59b-40aa06ac75c4
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CF-3414000D0O000000rwimUAA
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Health & Social Care
East Sussex Healthcare NHS Trust’s tender network
Assembling the network…
Similar open tenders
Sight testing and dispensing of spectacles to CYP with Special Educational Needs and Disabilities in Special Educational Settings in the West Midlands (6 Lots)
NHS Birmingham and Solihull Integrated Care Board
ITT Lung Cancer Screening Programme on behalf of NHS Derby and Derbyshire ICB
NHS Derby & Derbyshire Integrated Care Board